Real-time enrollment status for this advanced cancer clinical trial
Current Status
Recruiting
Checked: October 13, 2026 at 11:55 PM UTC
| NCT Number | NCT06060613 |
| Recruiting Status | Recruiting |
| Condition | Advanced Cancer |
| Phase | PHASE1 |
| Target Enrollment | 254 participants |
| Active Locations | 9 sites in the US |
| Sponsor | Obsidian Therapeutics, Inc. |
| Last Updated on CT.gov | October 5, 2026 (1 week ago) |
As of October 13, 2026: Clinical trial NCT06060613 is currently recruiting participants. This phase1 study for advanced cancer is actively seeking new participants at 9 locations across the United States. The study is sponsored by Obsidian Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06060613 is actively recruiting participants as of October 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06060613 was last updated 1 week ago (October 5, 2026). HelloStudys verifies this status automatically.